Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: “Correction: Practical aspects in the management of hypokalemic periodic paralysis”

Journal of Translational Medicine201412:198

https://doi.org/10.1186/1479-5876-12-198

  • Received: 7 July 2014
  • Accepted: 7 July 2014
  • Published:

The original article was published in Journal of Translational Medicine 2008 6:18

Text

After the publication of this work [1], we noticed an error in Table 1. The dosage of potassium citrate monohydrate should be 1622 mg, not 540 mg as originally stated. The corrected table is included below.
Table 1

(corrected): Potassium salts and their milligram to milliequivalent (or millimole) relationships

Spoken Name

Chemical Formula

mg

mEq K + (or mM K+)

Elemental potassium ion

K+

39.1

1

Potassium chloride (powder or tablets)

KCl

1500

20

Potassium bicarbonate (powder, tablets, or self-dissolving tablets)

KHCO3

650

6.5

Potassium citrate monohydrate

K3C6H5O7*H2O

1622

15 (i.e., 5 mEq of K3C6H5O7*H2O)

Potassium chloride 10% oral solution, 15 mL

KCl 10% oral solution

1500

20

Potassium chloride 20% oral solution, 15 mL

KCl 20% oral solution

3000

40

Potassium gluconate elixer, 15 mL

KC6H11O7

4680

20

Potassium gluconate tablets

KC6H11O7

500

2

The author apologises for this oversight.

Notes

Authors’ Affiliations

(1)
President and Medical Director, Periodic Paralysis Association, 155 West 68th Street, #1732, New York, NY 10023, USA
(2)
Department of Dermatology, The Mount Sinai Medical Center, New York, NY, USA

References

  1. Levitt JO: Practical aspects in the management of hypokalemic periodic paralysis. J Transl Med. 2008, 6: 28-10.1186/1479-5876-6-28. doi:10.1186/1479-5876-6-18View ArticleGoogle Scholar

Copyright

Advertisement